Susquehanna International Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-26,600
Closed -$382K 13284
2025
Q2
$382K Sell
26,600
-2,100
-7% -$28.8K ﹤0.01% 9804
2025
Q1
$416K Buy
28,700
+5,100
+22% +$72.4K ﹤0.01% 9314
2024
Q4
$310K Buy
+23,600
New +$326K ﹤0.01% 9766
2024
Q2
Sell
-10,900
Closed -$109K 12768
2024
Q1
$109K Buy
+10,900
New +$101K ﹤0.01% 11161
2023
Q3
Sell
-14,100
Closed -$200K 12565
2023
Q2
$200K Sell
14,100
-12,100
-46% -$170K ﹤0.01% 10267
2023
Q1
$391K Buy
26,200
+7,900
+43% +$120K ﹤0.01% 9150
2022
Q4
$272K Sell
18,300
-16,800
-48% -$274K ﹤0.01% 9334
2022
Q3
$580K Buy
35,100
+12,400
+55% +$250K ﹤0.01% 8084
2022
Q2
$477K Buy
+22,700
New +$463K ﹤0.01% 8379
2022
Q1
Sell
-8,700
Closed -$237K 13582
2021
Q4
$237K Sell
8,700
-45,900
-84% -$1.23M ﹤0.01% 11066
2021
Q3
$1.55M Buy
54,600
+26,100
+92% +$795K ﹤0.01% 6395
2021
Q2
$859K Sell
28,500
-10,100
-26% -$298K ﹤0.01% 8182
2021
Q1
$983K Sell
38,600
-9,000
-19% -$231K ﹤0.01% 7792
2020
Q4
$1.17M Buy
47,600
+11,900
+33% +$223K ﹤0.01% 6355
2020
Q3
$581K Buy
35,700
+22,900
+179% +$426K ﹤0.01% 7368
2020
Q2
$219K Sell
12,800
-8,600
-40% -$128K ﹤0.01% 8882
2020
Q1
$249K Buy
21,400
+11,900
+125% +$245K ﹤0.01% 8320
2019
Q4
$264K Sell
9,500
-10,800
-53% -$271K ﹤0.01% 8253
2019
Q3
$459K Buy
20,300
+4,000
+25% +$91.2K ﹤0.01% 7484
2019
Q2
$411K Buy
+16,300
New +$438K ﹤0.01% 7680
2019
Q1
Sell
-13,700
Closed -$452K 9439
2018
Q4
$452K Sell
13,700
-77,800
-85% -$3.13M ﹤0.01% 6221
2018
Q3
$4.27M Buy
91,500
+6,200
+7% +$285K ﹤0.01% 2868
2018
Q2
$3.69M Sell
85,300
-21,000
-20% -$1.01M ﹤0.01% 3103
2018
Q1
$5.91M Buy
106,300
+85,200
+404% +$4.67M ﹤0.01% 2337
2017
Q4
$1.13M Buy
+21,100
New +$996K ﹤0.01% 4985
2017
Q3
Sell
-43,000
Closed -$2.6M 9301
2017
Q2
$2.6M Buy
43,000
+31,200
+264% +$1.85M ﹤0.01% 3414
2017
Q1
$819K Sell
11,800
-3,300
-22% -$229K ﹤0.01% 5555
2016
Q4
$1.01M Sell
15,100
-3,100
-17% -$202K ﹤0.01% 5526
2016
Q3
$1.21M Sell
18,200
-41,200
-69% -$2.82M ﹤0.01% 4448
2016
Q2
$4.3M Sell
59,400
-60,500
-50% -$4.16M ﹤0.01% 2407
2016
Q1
$7.75M Buy
119,900
+35,000
+41% +$2.32M ﹤0.01% 1796
2015
Q4
$6.08M Buy
84,900
+79,200
+1,389% +$5.86M ﹤0.01% 2281
2015
Q3
$438K Buy
+5,700
New +$460K ﹤0.01% 7367
2015
Q1
Sell
-3,300
Closed -$218K 9701
2014
Q4
$218K Sell
3,300
-3,800
-54% -$232K ﹤0.01% 8664
2014
Q3
$389K Sell
7,100
-30,500
-81% -$1.73M ﹤0.01% 7635
2014
Q2
$2.19M Sell
37,600
-224,500
-86% -$13.2M ﹤0.01% 4498
2014
Q1
$16.2M Sell
262,100
-38,200
-13% -$2.22M 0.01% 1472
2013
Q4
$16M Buy
300,300
+176,900
+143% +$9.49M 0.01% 1587
2013
Q3
$6.2M Buy
123,400
+68,800
+126% +$3.36M ﹤0.01% 2437
2013
Q2
$2.5M Buy
+54,600
New +$2.44M ﹤0.01% 3562

Other funds holding MD

Susquehanna International Group's MD Position: Q1 2026 in Review

Susquehanna International Group increased its Pediatrix Medical (MD) stake by 35% in Q1 2026, buying an estimated $302K and bringing the position to 56,210 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #7410.

Susquehanna International Group first reported a position in MD in Q2 2013 and has held it in 40 quarters since. The position peaked at $3.89M in Q3 2015. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Susquehanna International Group held 56,210 shares of Pediatrix Medical worth $1.2M as of Q1 2026.
  • Susquehanna International Group bought 14,515 Pediatrix Medical shares in Q1 2026, an estimated $302K.
  • Pediatrix Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7410 holding.
  • Susquehanna International Group first reported a position in Pediatrix Medical in Q2 2013 and has held it in 40 quarters since.
  • Susquehanna International Group's Pediatrix Medical position peaked at $3.89M in Q3 2015.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.